Explore Stanford technologies available for licensing:

Researchers at Stanford University have created a novel mitral valve annuloplasty ring that can be adjusted in size off-bypass in response to regurgitation.

Stanford researchers have designed a novel tricuspid annuloplasty ring that minimizes the risk of interrupting cardiac conduction during implantation.

Stanford researchers have developed ultra-wideband amplification of near infrared signals for the first time on a photonic integrated circuit.

Using their novel fabrication process, Stanford researchers have produced the world's first practical titanium-sapphire laser on a chip, transforming a once-exclusive tabletop technology to the microscale.

Stanford researcher's invivo studies find that combining PARP inhibitors with a hypoxia activated prodrug delays tumor growth.

We are asking parties interested in commercializing this technology to please contact Stanford OTL by Friday, March 29, 2019.

Stanford researchers have developed a microfluidic system that uses optoelectronics for microdroplet manipulation to build synthetic oligonucleotides.

Researchers at Stanford have developed fusion proteins, containing ACE2 domain linked to a fragment of non-neutralizing anti-SARS-CoV-2 spike protein antibody, with a greater breadth of protection than previously described similar fusion proteins.

Researchers at Stanford have developed fully genetically-encodable lysosome-targeting chimeras which allow for the targeted delivery of various proteins into receiver cells.

Researchers at Stanford have developed methods for 3D printing and post-biomanufacturing of organoid slurries in a high yield stress matrix.

Stanford researchers have developed a novel fabrication method of high thermal conductivity 3D heat spreaders for semiconductor devices. Self-heating in the channel of semiconductor devices degrades device performance and shortens device lifetimes.

Current methods of genetically-engineered cells require precise integration of genetic material.

Stanford researchers have developed an in silico method, JEEPERS, that corrects DNA methylation errors at jagged-ends, improving cfDNA methylation profiling for early cancer detection and tissue-of-origin classification.

Theranostics represents a paradigm shift in cancer treatment, offering a more personalized and molecular approach to cancer diagnosis and treatment with striking efficacy and low toxicity.

Stanford researchers at the Kasevich Lab have developed a module that can attach to any standard optical system or sensor for wide-field, time-resolved imaging.

The Kasevich lab has expanded on an earlier invention ( Stanford Docket 18-388: " Efficient wide-field nanosecond imaging methods using Pockels ce